Literature DB >> 4609777

Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.

I G Karniol, I Shirakawa, N Kasinski, A Pfeferman, E A Carlini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609777     DOI： 10.1016/0014-2999(74)90129-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  83 in total

1.  Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

Authors:  Erin L Karschner; W David Darwin; Robert S Goodwin; Stephen Wright; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-11-15       Impact factor: 8.327

2.  Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.

Authors:  Shanna Babalonis; Margaret Haney; Robert J Malcolm; Michelle R Lofwall; Victoria R Votaw; Steven Sparenborg; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2016-12-14       Impact factor: 4.492

3.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

4.  Heterogeneity in the composition of marijuana seized in California.

Authors:  James Richard Burgdorf; Beau Kilmer; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

5.  Subjective and physiological effects after controlled Sativex and oral THC administration.

Authors:  E L Karschner; W D Darwin; R P McMahon; F Liu; S Wright; R S Goodwin; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

6.  Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.

Authors:  R N Takahashi; I G Karniol
Journal:  Psychopharmacologia       Date:  1975

7.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

Review 8.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.

Authors:  Mateus M Bergamaschi; Allan Barnes; Regina H C Queiroz; Yasmin L Hurd; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-03-15       Impact factor: 4.142

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.